2026. OUTCOMES OF SUBSEQUENT TREATMENT AFTER ATEZOLIZUMAB–BEVACIZUMAB FOR HEPATOCELLULAR CARCINOMA. Vietnam Journal of Community Medicine. 67, 10 (Oct. 2026). DOI:https://doi.org/10.52163/yhc.v67i10.6872.